---
title: "Why police departments can't quit Axon"
url: https://modern-mba.com/case/axon
sector: "Technology"
sector_url: https://modern-mba.com/sector/technology
published: 2023-06-26
updated: 2026-09-02
reading_time_minutes: 12
charts: 7
video: https://www.youtube.com/watch?v=Jf-mU-hdHyE
publisher: Modern MBA
license: All rights reserved. Quote with attribution and a link.
---

# Why police departments can't quit Axon

Axon spent the 2000s as a 200-person company called Taser International, fighting 49 simultaneous lawsuits while 26 states debated banning its only product. It now takes over $1.2 billion a year, mostly from software, because a regulatory mandate forced it to bolt a camera onto that product. This case study covers all three eras — the near-death decade, the cloud platform nobody wanted, and the subscription business that followed — and why the moat turned out to be data management rather than cameras.

## Key figures

- **$90M → $1.2B** — Annual revenue, 2011 to the 2020s
- **$20,000 → $200** — Cost of a licence plate reader, upfront versus per vehicle per month
- **90%+** — Share of customers now on a subscription plan

## The argument

The theory this case tests is that picking the right space beats executing well. Axon spent the 2000s as Taser International — 200 people, one product, and a decade of blunders. Twenty-six states debated banning Tasers, the DOJ was watching, Chicago suspended use, the SEC opened an investigation, and active lawsuits went from 15 in 2004 to 49 by 2007. Legal spending pushed SG&A from $7 million to over $40 million a year, eight to fifteen times R&D, on a hardware company's margins. Then it looked for growth in all the wrong places: a $180 electrified shotgun shell, a crowd-control device firing 24 Tasers at once, a multi-shot model too bulky for a duty belt whose unsold inventory was written off, and a genuine proposal to Taser bears.

The business that saved it was imposed from outside. Governments demanded accountability built into the weapon, so Axon built TaserCAM — a $400 accessory that recorded automatically the moment an officer flicked off the safety. It never exceeded 5% of revenue. What it taught the company was that video mattered in every encounter, not just the rare ones involving a Taser, and that nobody had thought about where any of that footage would live.

That question became the company. Evidence.com launched in 2010 as, technically, a custom interface over AWS S3, and made under $1 million in two years. After Michael Brown and Tamir Rice it became infrastructure. Revenue went from $90 million in 2011 to $1.2 billion, software and sensors overtook the weapon entirely, and over 90% of customers now pay a monthly per-officer subscription. The moat was never the camera.

## Charts

### The weapon found its market, then the lawsuits arrived

Annual revenue as Taser International. Twenty-fold growth to $68M by 2004, and the first decline the year twenty-six states began debating bans.

|  | US dollars |
| --- | --- |
| 2000 | $3M |
| 2001 | $7M |
| 2002 | $10M |
| 2003 | $24M |
| 2004 | $68M |
| 2005 | $48M |

Source: Modern MBA, “Why police departments can't quit Axon”, published June 2023. Chart: https://modern-mba.com/case/axon#chart-1 · Sources: https://modern-mba.com/case/axon#sources

### Lawyers cost it fifteen times what engineers did

Selling and administrative costs against research and development. Legal defense and compliance took SG&A from $2M to $43M while R&D stayed under $20M.

|  | SG&A costs | R&D costs |
| --- | --- | --- |
| 2000 | −$2M | $0M |
| 2001 | −$3M | $0M |
| 2002 | −$6M | $0M |
| 2003 | −$7M | $0M |
| 2004 | −$13M | −$1M |
| 2005 | −$26M | −$2M |
| 2006 | −$30M | −$3M |
| 2007 | −$33M | −$4M |
| 2008 | −$39M | −$13M |
| 2009 | −$43M | −$20M |
| 2010 | −$39M | −$11M |

Source: Modern MBA, “Why police departments can't quit Axon”, published June 2023. Chart: https://modern-mba.com/case/axon#chart-2 · Sources: https://modern-mba.com/case/axon#sources

### It made $307,000 in its first year

Evidence.com and first-generation recording hardware. Under $1.1M across the first two years, on a product that is now the larger half of the company.

|  | US dollars |
| --- | --- |
| 2010 | $307K |
| 2011 | $771K |
| 2012 | $2,453K |

Source: Modern MBA, “Why police departments can't quit Axon”, published June 2023. Chart: https://modern-mba.com/case/axon#chart-3 · Sources: https://modern-mba.com/case/axon#sources

### The cloud business nobody was waiting for

Evidence.com revenue in the era of dominance. It launched in 2010 and made under $1M in two years; a decade later it clears $372M on its own.

|  | US dollars |
| --- | --- |
| 2019 | $130M |
| 2020 | $177M |
| 2021 | $246M |
| 2022 | $372M |

Source: Modern MBA, “Why police departments can't quit Axon”, published June 2023. Chart: https://modern-mba.com/case/axon#chart-4 · Sources: https://modern-mba.com/case/axon#sources

### Software passed the weapon in 2022

Annual revenue of software and sensors against Tasers. The segment the company is named for is now the smaller half of it.

|  | Software & sensors | Tasers |
| --- | --- | --- |
| 2019 | $249M | $282M |
| 2020 | $314M | $367M |
| 2021 | $426M | $437M |
| 2022 | $658M | $532M |

Source: Modern MBA, “Why police departments can't quit Axon”, published June 2023. Chart: https://modern-mba.com/case/axon#chart-5 · Sources: https://modern-mba.com/case/axon#sources

### The camera on the chest, not the one on the glasses

Sales by recording product. Axon Body tripled to $124M while Axon Flex, the head-mounted version, fell to $3M — the hardware bet that did not land.

|  | Axon Body | Axon Flex |
| --- | --- | --- |
| 2019 | $44M | $6M |
| 2020 | $57M | $4M |
| 2021 | $75M | $4M |
| 2022 | $124M | $3M |

Source: Modern MBA, “Why police departments can't quit Axon”, published June 2023. Chart: https://modern-mba.com/case/axon#chart-6 · Sources: https://modern-mba.com/case/axon#sources

### A billion in revenue and one profitable year in four

Revenue against operating income. Axon doubled the top line between 2019 and 2022 and only cleared an operating profit in the last of those years.

|  | Revenue | Operating income |
| --- | --- | --- |
| 2019 | $531M | −$6M |
| 2020 | $681M | −$14M |
| 2021 | $863M | −$168M |
| 2022 | $1,189M | $93M |

Source: Modern MBA, “Why police departments can't quit Axon”, published June 2023. Chart: https://modern-mba.com/case/axon#chart-7 · Sources: https://modern-mba.com/case/axon#sources


## Takeaways

1. American policing is a **$100 billion** annual business, and the West has spent the past decade converting it from an opaque institution into one expected to produce evidence of its own conduct. **Axon is the company that made that possible**, and its watermark is on essentially every piece of bodycam footage that reaches the internet.
2. **It nearly died first.** In the 2000s, Taser International was a **200-person, single-product company** at a moment when many people found the idea of **50,000 volts** through barbed darts unacceptable — and a single product is a fatal exposure when everyone is calling for it to be banned.
3. The pressure was institutional, not just public. **26 states were actively debating bans**, the **DOJ** was monitoring, **Chicago suspended Taser use**, and the **SEC opened an investigation into product safety** — alongside wrongful death suits from families and injury suits from officers Tasered during mandatory certification.
4. **Litigation, not manufacturing, became the cost base.** Active lawsuits went from **15 in 2004 to 49 by 2007**, falling back to 16 only by 2014 with **over 100 dismissed** in Axon's favor. **SG&A ballooned from $7M in 2003 to over $40M by 2009 — eight to fifteen times R&D** — and flattened the bottom line to single digits.
5. The science eventually held. Courts ruled Tasers **did not cause 90%** of the claimed injuries or deaths, autopsies attributed many to overdose, and investigations closed without judgment — but the vindication took roughly a decade to arrive.
6. The product itself was never as reliable as the pitch. A Taser fires **two darts on compressed nitrogen**, and **both must penetrate and stay in the skin** — so thick clothing, a flailing arm, a gust of wind or a tangled wire defeats it. Cartridges are single-use and proprietary, sold at **$16 to police and $30 to civilians**, and were the **second-highest grossing product** in that decade.
7. **The search for growth produced a decade of misfires.** The military wanted wireless Tasers effective at **100 yards** — impossible then and now. Axon instead shipped an underbarrel rail attachment, an undeployed non-lethal land mine, the **$180-a-round XREP shotgun shell**, and **Shockwave**, which fired 24 Tasers at once and was quietly discontinued.
8. Its own R&D compounded the problem. The **X3** finally allowed multiple shots before reloading — the weapon's oldest criticism — and was **too bulky and heavy for a standard duty belt**. It sold below expectations, **the unsold inventory was discarded at a loss**, and the older X26 stayed the better seller.
9. **After three consecutive years of operating losses**, the company proposed adjacent markets including animal control, with its founder publicly suggesting a Taser could incapacitate a bear — a device that was already inconsistent on humans. The idea was killed about as fast as it was raised.
10. **The rescue was a compliance requirement, not a product decision.** Governments demanded accountability built into the weapon itself, so Axon shipped **TaserCAM**, a **$400 backwards-compatible accessory** recording an hour of audio and video. **The French National Police and Gendarmerie both refused to adopt Tasers without it.**
11. **Its best feature was the absence of a button.** TaserCAM began recording the moment an officer switched off the Taser's safety — capturing the moments before, during and after — so the evidence did not depend on a person remembering to create it under stress.
12. **TaserCAM never mattered commercially: under 5% of revenue through the 2010s.** What it produced was the insight — video is valuable in *every* encounter, not the rare ones involving a Taser — and a problem nobody owned: footage piling up by the gigabyte with no answer for storage, retention, tamper-proofing, backup or search.
13. **Evidence.com was not an engineering achievement and that was fine.** Launched in 2010, it was technically a custom interface in front of **AWS S3** — but for most agencies it was their first contact with cloud infrastructure at all. It and the ATC headcam made **under $1 million combined in their first two years.**
14. **The form factor took years of wrong answers.** Axon dropped touchscreens after concluding it should not be building wearable computers, tried head-mounted cameras, then glasses with **Axon Flex** at **$4-6M a year**, before accepting that the conventional body camera did not need reinventing. Even Google Glass did not worry them: *"it's not the camera, stupid, it's the backend."*
15. **Then the tailwind arrived and the numbers changed shape.** Revenue went from **$90M in 2011 to $530M by 2019**; Evidence.com from **$30M to $130M**; body cameras from **$4M in 2015 to $44M in 2019**. In the 2020s bodycams doubled again to **$124M** and Evidence.com to **$371M**, taking total revenue from **$680M to $1.2B in two years** — with software and sensors now the majority of it.
16. **The endgame is subscription, and the pricing is where the trial and error paid off.** Over **90% of customers** are on a plan; the Officer Safety Plan bundles a Taser, bodycam, Evidence.com licence, unlimited storage and full warranty for **$99-$239 per officer per month**, with cheaper tiers for small agencies. Hardware refreshes automatically — **Tasers every 5 years, cameras every 2.5** — and **cartridges are excluded, still worth 15-18% of revenue every year.** **Axon Fleet did the same to licence plate readers, replacing a $20,000 upfront system with $200 a month and growing from $3M in 2017 to over $60M by 2022.**

## Common questions

### How does Axon make money?

Increasingly from software rather than weapons. Software and sensors — chiefly Evidence.com, the cloud platform where agencies store and manage footage — became the majority of revenue, growing from $314 million in 2020 to $658 million by 2022. Over 90% of customers are on subscription plans, with the Officer Safety Plan bundling a Taser, body camera, Evidence.com licence, unlimited storage and warranty for $99 to $239 per officer per month. Taser cartridges, deliberately excluded from those bundles, still account for 15 to 18% of revenue every year.

### Why did Taser International change its name to Axon?

Because the weapon stopped being the business. The company spent the 2000s as a single-product maker fighting for its life, then discovered through a regulatory requirement that video and evidence management mattered far more. By the late 2010s the software and sensor segment was earning as much as the entire Taser line, and today it is the majority of revenue. The Taser remains a top-three product and grows 20 to 30% a year, but it contributes a steadily smaller share of the top line.

### What nearly killed Taser International in the 2000s?

Litigation and political pressure over its only product. After deaths following Taser deployments, 26 states debated bans, the DOJ monitored the situation, Chicago suspended use, and the SEC opened a product safety investigation. Active lawsuits rose from 15 in 2004 to 49 by 2007. Legal costs pushed SG&A from $7 million to over $40 million a year — eight to fifteen times R&D spending — and the company posted three consecutive years of operating losses. Courts eventually ruled Tasers did not cause 90% of the claimed injuries or deaths, but vindication took roughly a decade.

### What is Evidence.com?

Axon's cloud platform for storing and managing police footage, and the reason the company is worth what it is. It launched in 2010 as, technically, a custom interface in front of Amazon S3 — no great engineering feat — but for most agencies it was their first exposure to cloud infrastructure at all. It solved the problem nobody else had noticed: bodycam footage accumulating by the gigabyte with no answer for retention, tamper-proofing, chain of custody, backup or search. It grew from $30 million in 2010 to $371 million by 2022.

### Why did body cameras suddenly take off?

Because public pressure made them urgent almost overnight. Through the early 2010s agencies were not opposed to cameras but saw no reason to hurry, and Axon's early wearables sold in the low millions. The killings of Michael Brown and Tamir Rice — the latter ending without judgment partly because the available footage was too poor to interpret — turned incident recording from a nice-to-have into a requirement, in the US and abroad. George Floyd and Breonna Taylor intensified it further, doubling bodycam sales from $57 million in 2020 to over $124 million by 2022.

### What is Axon's competitive moat?

Data management, not hardware. Competitors can build a camera; what they could not match was one vendor supplying connected hardware and a managed software backend together, as modular services rather than fragile on-premise systems. Axon said as much publicly when Google Glass launched — an agency using someone else's camera still needs somewhere to put the footage. Agencies that built DIY alternatives, manually exporting and storing video on local servers or Google Drive, found it untenable and came back.

### What was the TaserCAM and why did it matter?

A $400 backwards-compatible accessory that recorded an hour of audio and video, built because governments demanded accountability be built into the weapon — the French National Police and Gendarmerie both refused to adopt Tasers without it. Its clever feature was requiring no action: recording began the moment an officer flicked off the Taser's safety, capturing before, during and after. Commercially it never exceeded 5% of revenue. Strategically it taught Axon that video was valuable in every encounter and that nobody had solved where the footage should live.

### Is the Taser still important to Axon?

Yes, and there is room left in it. The Taser remains a top-three product growing 20 to 30% a year, and cartridges alone are 15 to 18% of revenue. The upside is that it still is not standard issue — even the NYPD, with a budget over $10 billion, allocates a shared pool of Tasers rather than arming every officer. Axon's argument is that better hardware closes that gap: the Taser 10 improves clothing penetration and fires up to ten shots from one cartridge, of which only two need to land.

## Discussion

- Axon's decisive product came from a regulatory mandate it did not want. How often is the requirement imposed on a company more valuable than the strategy it chose for itself — and can that be planned for?
- Evidence.com was a custom interface over S3 that made under $1 million in two years and became the majority of the business. What separates a product that is early from one that is simply wrong?
- The company spent years on headcams and camera glasses before accepting the body camera form factor. What does that say about the cost of trying to reinvent something that already works?
- Axon competes on merit in a slow bureaucratic public-sector process rather than building walled gardens against churn. Which selling environment produces a better company, and why?
- The thesis is that picking the right space beats executing well, since Axon executed badly for a decade and won anyway. Does that hold, or did the decade of mistakes build the expertise that let it capitalize?

## Sources

Net sales by product and segment, SG&A and R&D spend, active litigation counts, subscription mix and per-officer pricing from Axon Enterprise (formerly TASER International) annual reports and 10-K filings, 2003 through 2022; product pricing, launch dates and discontinuations as disclosed by the company; executive commentary from earnings calls; NYPD budget from published city figures

---

From [Modern MBA](https://modern-mba.com/). Read this case in full at [https://modern-mba.com/case/axon](https://modern-mba.com/case/axon), or watch the episode at https://www.youtube.com/watch?v=Jf-mU-hdHyE.